Intravenous Iron in Heart Failure: Reading an Updated Meta-analysis
Study at a glance
- Publication type: Updated meta-analysis of randomized controlled trials
- What it examined: This review updated the randomised-trial evidence on intravenous iron for heart failure with iron deficiency.
- Key point: The authors searched PubMed, Embase and the Cochrane Library through 20 April 2024. A meta-analysis can increase precision, but its conclusions remain dependent on the quality, populations and endpoints of the included trials.
Why it matters
This article is useful as an evidence map. It should be interpreted alongside individual trial design and current clinical guidance, rather than as a substitute for patient-level assessment.
Source
Wang H, et al. Impact of Intravenous Iron in patients with heart failure and Iron Deficiency: an updated Meta-analysis of Randomized controlled trials. BMC Cardiovasc Disord. 2024;24:695. PMID: 39627692. View the PubMed record.
This educational summary is based on the cited publication and is not medical advice. Clinical decisions should be made with an appropriately qualified healthcare professional.

Previous Post
Tirzepatide in HFpEF With Obesity: Results From the SUMMIT Trial
Next Post
Remote Monitoring in Heart Failure: What National Real-World Data Can Tell Us


